Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
7.66
-0.14 (-1.79%)
Feb 27, 2026, 4:00 PM EST - Market closed
Intensity Therapeutics Stock Forecast
INTS's stock price has decreased by -86.07% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Intensity Therapeutics stock have an average target of 56.25, with a low estimate of 37.5 and a high estimate of 75. The average target predicts an increase of 634.33% from the current stock price of 7.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 20, 2025.
Analyst Ratings
The average analyst rating for Intensity Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $100 → $38 | Buy | Maintains | $100 → $38 | +389.56% | Aug 20, 2025 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $75 | Hold → Strong Buy | Upgrades | $75 | +879.11% | Aug 12, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $213 | Strong Buy | Initiates | $213 | +2,674.15% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $125 | Strong Buy | Reiterates | $125 | +1,531.85% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $125 | Strong Buy | Initiates | $125 | +1,531.85% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.34
from -29.24
EPS Next Year
-0.22
from -0.34
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.35 | -0.20 | ||||
| Avg | -0.34 | -0.22 | ||||
| Low | -0.33 | -0.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.